Metabolic neutrality of combined verapamil-trandolapril treatment in contrast to beta-blocker-low-dose chlortalidone treatment in hypertensive type 2 diabetes

Schneider M, Lerch M, Papiri M, Buechel P, Boehlen L, Shaw S, Risen W, Weidmann P. Metabolic neutrality of combined verapamil-trandolapril treatment in contrast to beta-blocker-low-dose chlortalidone treatment in hypertensive type 2 diabetes. Journal of hypertension 1996; 14:669-77.